Cite
Tumor-associated miRNAs activated HCR-DNAzyme theranostic nanosystem to trigger innate- and adaptive-immune responses for long-term immunotherapy.
MLA
Chen, Chao, et al. “Tumor-Associated MiRNAs Activated HCR-DNAzyme Theranostic Nanosystem to Trigger Innate- and Adaptive-Immune Responses for Long-Term Immunotherapy.” Chemical Engineering Journal, vol. 473, Oct. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cej.2023.145192.
APA
Chen, C., Du, S., Lu, Q., Liu, K., Pan, Y., Jiang, Y., Yang, J., Han, X., & Song, Y. (2023). Tumor-associated miRNAs activated HCR-DNAzyme theranostic nanosystem to trigger innate- and adaptive-immune responses for long-term immunotherapy. Chemical Engineering Journal, 473, N.PAG. https://doi.org/10.1016/j.cej.2023.145192
Chicago
Chen, Chao, Shiyu Du, Qianglan Lu, Kunguo Liu, Yongchun Pan, Yiqun Jiang, Jingjing Yang, Xin Han, and Yujun Song. 2023. “Tumor-Associated MiRNAs Activated HCR-DNAzyme Theranostic Nanosystem to Trigger Innate- and Adaptive-Immune Responses for Long-Term Immunotherapy.” Chemical Engineering Journal 473 (October): N.PAG. doi:10.1016/j.cej.2023.145192.